Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis
Abstract Background The clinical significance of stem cell therapy in the treatment of dilated cardiomyopathy remains unclear. This systemic appraisal and meta-analysis aimed to assess the efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy. After searching the PubMed, E...
Main Authors: | Shu-Ling Rong, Ze-Kun Wang, Xue-Dong Zhou, Xiao-Lin Wang, Zhi-Ming Yang, Bao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-019-1966-4 |
Similar Items
-
HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy
by: B. Jin, et al.
Published: (2016-01-01) -
Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets
by: Ahmad Alimadadi, et al.
Published: (2020-01-01) -
Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy
by: Angita Jain, et al.
Published: (2021-05-01) -
Reversible dilative cardiomyopathy after electrical injury: a case report
by: Eirini Liodaki, et al.
Published: (2018-11-01) -
Serum Zinc Level in Dilated and Ischemic Cardiomyopathy
by: Seyed Mahmood Nouraei, et al.
Published: (2007-07-01)